Pharmacological Preconditioning of Mesenchymal Stem Cells with Trimetazidine (1-[2,3,4-Trimethoxybenzyl]piperazine) Protects Hypoxic Cells against Oxidative Stress and Enhances Recovery of Myocardial Function in Infarcted Heart through Bcl-2 Expression

Sheik Wisel(Lung Institute), Periannan Kuppusamy(The Ohio State University)
Journal of Pharmacology and Experimental Therapeutics
February 14, 2009
Cited by 135


Related Papers